in patients with presumed metabolic dysfunction-associated steatohepatitis (MASH), has been accepted as a late-breaking poster presentation at the European Association for the Study of the Liver ...

We completed a large-scale project (supported by a SSHRC Insight Grant, 2014-2018) exploring various aspects of the history and use of meta-analysis, the debates surrounding its employment in ...

MetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. The company is currently developing DA-1726 for the treatment of obesity and is developing ...